How mitochondria produce reactive oxygen species by Murphy, Michael P.
Biochem. J. (2009) 417, 1–13 (Printed in Great Britain) doi:10.1042/BJ20081386 1
REVIEW ARTICLE
How mitochondria produce reactive oxygen species
Michael P. MURPHY1
MRC Dunn Human Nutrition Unit, Hills Road, Cambridge CB2 0XY, U.K.
The production of ROS (reactive oxygen species) by mammalian
mitochondria is important because it underlies oxidative damage
inmanypathologiesandcontributestoretrograderedoxsignalling
from the organelle to the cytosol and nucleus. Superoxide (O2
•−)
is the proximal mitochondrial ROS, and in the present review
I outline the principles that govern O2
•− production within
the matrix of mammalian mitochondria. The ﬂux of O2
•− is
related to the concentration of potential electron donors, the local
concentration of O2 and the second-order rate constants for the
reactions between them. Two modes of operation by isolated
mitochondriaresultinsigniﬁcantO2
•− production,predominantly
from complex I: (i) when the mitochondria are not making ATP
and consequently have a high  p (protonmotive force) and a
reduced CoQ (coenzyme Q) pool; and (ii) when there is a high
NADH/NAD
+ ratiointhemitochondrialmatrix.Formitochondria
that are actively making ATP, and consequently have a lower  p
andNADH/NAD
+ ratio,theextentofO2
•− productionisfarlower.
The generation of O2
•− within the mitochondrial matrix depends
critically on  p, the NADH/NAD
+ and CoQH2/CoQ ratios and
the local O2 concentration, which are all highly variable and difﬁ-
culttomeasureinvivo.Consequently,itisnotpossibletoestimate
O2
•− generation by mitochondria in vivo from O2
•−-production
rates by isolated mitochondria, and such extrapolations in the
literature are misleading. Even so, the description outlined here
facilitates the understanding of factors that favour mitochondrial
ROSproduction.Thereisaclearneedtodevelopbettermethodsto
measuremitochondrialO2
•− andH2O2 formationinvivo,asuncer-
taintyaboutthesevalueshampersstudiesontheroleofmitochon-
drial ROS in pathological oxidative damage and redox signalling.
Key words: complex I, hydrogen peroxide, mitochondrion,
reactive oxygen species (ROS), respiratory chain, superoxide.
INTRODUCTION
Mitochondria are an important source of ROS (reactive oxygen
species) within most mammalian cells [1–8]. This ROS
production contributes to mitochondrial damage in a range of
pathologies and is also important in redox signalling from the
organelle to the rest of the cell [3,9]. Consequently, knowledge of
how mitochondria produce ROS is vital to understand a range
of currently important biomedical topics (Figure 1). The ﬁrst
report that the respiratory chain produced ROS came in 1966
[10], followed by the pioneering work of Chance and colleagues
who showed that isolated mitochondria produce H2O2 [4,11,12].
Later, it was conﬁrmed that this H2O2 arose from the dismutation
of superoxide (O2
•−) generated within mitochondria [13,14].
The parallel discovery that mitochondria contain their own
SOD (superoxide dismutase), MnSOD, conﬁrmed the biological
signiﬁcance of mitochondrial O2
•− production [15]. Since then, a
huge literature has developed on the sources and consequences of
mitochondrial ROS production, which I will not attempt to cover
systematically. Instead, I shall develop a consensus about how
mitochondria produce ROS and indicate current uncertainties and
future issues to be addressed. The focus of the present review is
the production of the proximal mitochondrial ROS, O2
•−,i nt h e
mitochondrial matrix by the core metabolic machinery present in
the mitochondrial inner membrane and matrix. Other potentially
important ROS sources associated with the mitochondrial outer
membrane or intermembrane space will not be considered [1,5].
The aim is to provide a useful resource for those working
on mitochondrial ROS production, to facilitate the design
and interpretation of experiments, and to stimulate new ap-
proaches.
O2
•−, THE PROXIMAL MITOCHONDRIAL ROS
Within mitochondria, O2
•− is produced by the one-electron
reduction of O2. Therefore it is the kinetic and thermodynamic
factorsunderlyingtheinteractionofpotentialone-electrondonors
with O2 that control mitochondrial ROS production. Having two
unpaired electrons in antibonding orbitals with parallel spins
makes ground-state O2 accept one electron at a time [16]. The
standard reduction potential for the transfer of an electron to O2
to form O2
•− is −160 mV at pH 7 [16], for a standard state of 1 M
O2.AsthepKa ofO2
•− is4.7[16],thisstandardreductionpotential
isinvariantacrossmostbiologicalpHvalues.Theactualreduction
potential that determines the thermodynamic tendency of O2
to form O2
•−, Eh, will vary with the relative concentrations of
O2 and O2
•−:
Eh(mV) =− 160 + 61.5log 10
[O2]
[O2
•−]
(1)
The [O2] in air-saturated aqueous buffer at 37◦C is approx.
200 μM [17]; however, mitochondria in vivo are exposed to a
considerably lower [O2] that varies with tissue and physiological
state [18]. This occurs because the mitochondrial [O2] in vivo
is largely set by the extracellular [O2] in the tissue, which is
itself determined by local O2 delivery and consumption [18].
In addition, [O2] decreases on going from the extracellular
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Figure 1 Overview of mitochondrial ROS production
ROS production by mitochondria can lead to oxidative damage to mitochondrial proteins, membranes and DNA, impairing the ability of mitochondria to synthesize ATP and to carry out their wide
range of metabolic functions, including the tricarboxylic acid cycle, fatty acid oxidation, the urea cycle, amino acid metabolism, haem synthesis and FeS centre assembly that are central to the
normal operation of most cells. Mitochondrial oxidative damage can also increase the tendency of mitochondria to release intermembrane space proteins such as cytochrome c (cyt c) to the cytosol
by mitochondrial outer membrane permeabilization (MOMP) and thereby activate the cell’s apoptotic machinery. In addition, mitochondrial ROS production leads to induction of the mitochondrial
permeability transition pore (PTP), which renders the inner membrane permeable to small molecules in situations such as ischaemia/reperfusion injury. Consequently, it is unsurprising that
mitochondrial oxidative damage contributes to a wide range of pathologies. In addition, mitochondrial ROS may act as a modulatable redox signal, reversibly affecting the activity of a range of
functions in the mitochondria, cytosol and nucleus.
environment to the mitochondrion, owing to O2 consumption by
cytochrome oxidase [18,19]. Plausible estimates for the mito-
chondrial [O2] in vivo are in the range 3–30 μM [2]. The steady-
state intramitochondrial [O2
•−] is difﬁcult to measure accurately,
butitislikelytobeverylowbecauseofmicromolarconcentrations
of MnSOD in the mitochondrial matrix (e.g. 11 μMM n S O D
in rat liver mitochondria [20]). This MnSOD will very rapidly
(k≈2.3×10
9 M
−1 · s
−1) catalyse dismutation of O2
•− to H2O2
by a process that is ﬁrst-order with respect to [O2
•−] [2,4,5].
Furthermore, by acting as a very effective O2
•− sink, MnSOD will
favour the reaction of O2 with electron donors to form O2
•−,i n
effectincreasingtheﬂuxofelectronsfromelectrondonorstoH2O2
[21,22]. Tentative estimates for [O2
•−] within the mitochondrial
matrixareintherange10–200pM[4,5].Bycombiningthesewith
a plausible intramitochondrial [O2]o f2 5μM[ 2 ] ,e q n( 1 )g i v e s
Eh in the range 150–230 mV for the reduction of O2 to O2
•−.E v e n
for a low [O2]o f1μMa n dah i g h[ O 2
•−] of 200 pM, the Eh value
obtained is 68 mV.
Therefore, in vivo, the one-electron reduction of O2 to O2
•− is
thermodynamically favoured, even by relatively oxidizing redox
couples, and a wide range of electron donors within mitochondria
could potentially carry out this reaction [1]. However, only
a small proportion of mitochondrial electron carriers with the
thermodynamic potential to reduce O2 to O2
•− do so. Under most
circumstances, small-molecule electron carriers such as NADH,
NADPH, CoQH2 (reduced coenzyme Q) and glutathione (GSH)
donotreactwithO2 togenerateO2
•−.Instead,mitochondrialO2
•−
production takes place at redox-active prosthetic groups within
proteins, or when electron carriers such as CoQH2 are bound
to proteins, and it is the kinetic factors that favour or prevent
the one-electron reduction of O2 to O2
•− by these that determine
mitochondrial O2
•− production.
THE CONTROL OF O2
•− PRODUCTION BY PROTEIN-BOUND
REDOX GROUPS
The factors determining the rate of O2
•− production by mito-
chondria are relatively straightforward. The ﬁrst is the concen-
tration of the enzyme or protein [E] containing electron carriers
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that can exist in a redox form able to react with O2 to form
O2
•−. The second is the proportion (PR) of this enzyme’s electron
carrier present in a redox form that can react with O2.A sm a n y
redox-active groups exist only transiently in a state that can react
with O2, PR is a time-average. The remaining factors are the
local [O2] and the second-order rate constant (kE) for the reaction
of that electron carrier with O2 to form O2
•−. For a given enzyme
or protein (E), the rate of O2
•− production is:

d[O2
•−]
dt

E
= kE[O2]PR[E] (2)
This can be extended to consider several potential electron-
donor sites within mitochondria, and also to take into account
multiple electron donor sites within a single protein:

d[O2
•−]
dt

Total
= [O2]

i
(kEPR[E])i (3)
The concentration of the enzyme responsible for O2
•− produc-
tion, [E], will vary with organism, tissue, state, age or hormonal
status, and may underlie many of the changes in maximum ROS
production capacity between tissues [23]; for example, complex I
content may explain the different maximum capacities of pigeon
and rat heart mitochondria [24].
As the apparent Km of cytochrome oxidase for O2 is very
low (<1 μM [25]), changes in [O2] should have little direct
effect on mitochondrial function and instead are most likely to
interact by affecting O2
•− production. The generation of O2
•− or
H2O2 byisolatedrespiratorycomplexes,SMPs(submitochondrial
particles) or mitochondria increases when [O2] is raised above
the normal atmospheric level of 21% O2, and this increase is
roughly proportional to [O2], at least over the lower range of
supraphysiological [O2] [4,12,26–28]. Fewer studies have looked
at the effects of decreasing [O2], but O2
•− production by isolated
complex I decreases linearly with lowered [O2] [28], and there
is a decrease in H2O2 production by isolated mitochondria when
[O2] is lowered below that of air-saturated medium [27,29,30].
However, in one detailed study, the rate of H2O2 production did
not change as [O2] was lowered from ∼200 μMt o∼5 μMa n d
only decreased when [O2] was lowered below 5 μM [29]; further
investigation of this important issue is required to see whether it
arises due to the technical difﬁculties of measuring low levels of
H2O2 production or whether it reﬂects a genuine phenomenon.
The dependence of mitochondrial H2O2 production on [O2]i s
likelytobeanimportantfactorinthevariationofROSproduction
in vivo because extracellular [O2] varies with physiological
state, and there are [O2] gradients from the circulation to the
mitochondria where O2 consumption by cytochrome oxidase
decreases [O2] locally [18,19]. Thus increasing or decreasing the
rate of O2 consumption by mitochondria may be an important
aspect for modifying O2
•− production in vivo by altering the local
[O2] [19]. Furthermore, as O2 is approx. 3-fold more soluble
within membranes than in water [31], O2 may be concentrated
close to electron carriers within the membrane. Physiological
levels of nitric oxide (NO
•) compete with O2 for cytochrome
oxidase when [O2] is low, effectively raising the apparent Km of
this enzyme [32–35], and may thus alter the local [O2] around
mitochondria, leading to changes in O2
•− production [36–38].
Probably the most important factor that determines O2
•− pro-
duction by mitochondria is the proportion, PR, of a given electron
carrierthatisreactivewithO2 toformO2
•−,asPR respondsrapidly
to a range of biological situations. The relationship between PR
and the overall reduction state of an electron carrier group in a
protein may be complicated, as the redox form that donates an
electron to O2 is not necessarily fully reduced. Instead, a partially
reduced form, such as a semiquinone, that can respond to the
cumulativereductionofanelectroncarriersystemmaybethecrit-
icalelectrondonor.Foranyelectroncarrier,PR willbeaffectedby
changesinthecarrier’sEm andinitsrateofelectronsupplyandre-
lease, all of which can be altered by inhibition, damage, mutation
or post-translational modiﬁcation to protein complexes distal or
proximaltothesite,ortotheproteinitself.Manyotherfactorscan
have an impact on PR by affecting these parameters, with changes
in p(protonmotiveforce)likelytobeparticularlyimportantasit
signiﬁcantlyaffectsthePR ofelectroncarriersanditvariesrapidly
in response to changes in mitochondrial ATP synthesis.
TheﬁnalfactoraffectingtherateofO2
•− productionbyelectron
carriers within proteins is the second-order rate constant (kE)
of their reaction with O2. The reaction between protein-bound
electroncarriersandO2 toformO2
•− isgenerallythoughttooccur
through an outer-sphere mechanism described by the Marcus
theory [39,40]. In this mechanism, an electron tunnels from the
electrondonortoO2,andtherateisverydependentonthedistance
between O2 and the electron donor [39,40]. This is similar to
electron movement down the respiratory chain which occurs
by electron tunnelling from carrier to carrier, with a maximum
distance of approx. 14 Å (1 Å=0.1 nm) between each carrier for
effective tunnelling to occur [41]. Similar distance constraints
probably apply to the reaction of protein-bound electron carriers
in the respiratory chain with O2 to form O2
•−, with the bulk of
the protein acting as an insulator to keep O2 at a safe distance
from the carriers and thereby minimize O2
•− production [41].
Consequently, O2
•− production will probably occur at sites where
O2 canapproachcloselytoelectroncarriers,suchasatactivesites
exposed to the aqueous phase or to the membrane core.
The rate of electron transfer from protein electron carriers to
O2 has been investigated for ﬂavoenzymes that activate O2,w h e r e
thereductionofO2 toO2
•− isoftenaprecursortofurtherreactions
[42].Fortheﬂavoenzymeglucoseoxidase,therateofO2 reduction
to H2O2 is ∼10
6 M
−1 · s
−1 [39], and, as the rate-limiting step is
O2 reduction to O2
•− [39], this indicates that O2
•− production
by protein-bound electron carriers can be rapid. Of course, the
production of H2O2 is a consequence of the normal physiological
function of glucose oxidase, and for other ﬂavoproteins, where
electron transfer to O2 to form O2
•− may be a side reaction, the
rate varies over ﬁve orders of magnitude [43]. Even so, the rate of
reduction of O2 by the reduced FMN of complex I to form O2
•−
is ∼40 O2
•− · min
−1 [28], corresponding to a second-order rate
constant of ∼10
3 M
−1 · s
−1. Thus the second-order rate constants
(kE)f o rO 2
•− production as a side reaction by protein-bound
electroncarrierscanberapid,althoughitislikelytovarymarkedly
with the environment of the electron donor and its accessibility
to O2. Therefore alterations to a protein that enabled O2 to
approach more closely to the electron carrier, such as by damage,
mutation, post-translational modiﬁcation, conformational change
or quaternary interactions, could lead to dramatic changes in the
rateofO2
•− production,andpotentiallyplayaregulatoryfunction.
Such factors determining the second-order rate constant for the
reaction of O2 with protein electron carriers could determine
mitochondrial O2
•− production, but little is known about how
kE may be varied by different enzymes within mitochondria.
MEASUREMENT OF O2
•− PRODUCTION BY ISOLATED
MITOCHONDRIA
Although many puriﬁed mitochondrial proteins can be manipu-
lated so as to produce O2
•−, the physiological relevance of this is
limited. Therefore it is important to understand O2
•− production
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Figure 2 Measurement of H2O2 production by isolated mitochondria
The production of O2
•− within the mitochondrial matrix, intermembrane space and outer membrane leads to the formation of H2O2 from SOD-catalysed dismutation. Some O2
•− can react directly
with nitric oxide (NO•) to form peroxynitrite (ONOO−). There are also sources outside mitochondria that produce H2O2 directly. The H2O2 efﬂux from mitochondria can be measured following
reaction with a non-ﬂuorescent substrate such as Amplex Red in conjunction with horseradish peroxidase (HRP) to form a ﬂuorescent product, resoruﬁn. Within mitochondria H2O2 is degraded by
glutathione peroxidases (GPx) or peroxiredoxins (Prx) which depend on glutathione (GSH) and thioredoxin-2 (Trx) for their reduction respectively. Glutathione disulﬁde (GSSG) is reduced back to
GSH by glutathione reductase (GR). Trx is reduced by thioredoxin reductase-2 (TrxR). Both enzymes receive reducing equivalents from the NADPH pool, which is kept reduced by the  p-dependent
transhydrogenase (TH), and by isocitrate dehydrogenase (ICDH). Note that many mitochondrial preparations, particularly those from the liver, contain large amounts of catalase contamination. The
effects of such extramitochondrial H2O2 sinks are not indicated here as they are usually accounted for by appropriate H2O2 calibration curves in the presence of mitochondria. ox, oxidized; red,
reduced. An animated version of this Figure can be seen at http://www.BiochemJ.org/bj/417/0001/bj4170001add.htm.
within isolated mitochondria under conditions that mimic those
that may arise in vivo under physiological or pathological condi-
tions. A constraint of using isolated mitochondria is that the sys-
tem is complicated and difﬁcult to manipulate. In particular, the
direct measurement of O2
•− within mitochondria is challenging
due to its rapid dismutation in the presence of ∼10 μMM n S O D
(k≈2×10
9 M
−1 · s
−1 [2,5]),whichleadstoverylowsteady-state
matrix [O2
•−] and competes with O2
•− detection systems [44].
{The spontaneous dismutation of O2
•− (k≈10
6 [16]) is less
important because it is second-order with respect to [O2
•−],
which is very low in the presence of MnSOD.} Studies have
been carried out on O2
•− production by mitochondria lacking
MnSOD [44], but there is always the concern that the absence
of MnSOD may decrease the ﬂux of O2
•− by allowing the back
reaction between O2
•− and the electron donor [21,22], as well
as having the potential to damage the system [45,46]. The use
of O2
•−-sensitive dyes such as hydroethidine and MitoSOX
TM
[47–50], measurement of the reaction of O2
•− with compounds
to form chemiluminescent products [44,51], spin trapping [52]
or measurement of the inactivation rate of aconitase [53] do
provide useful information on mitochondrial O2
•− production.
Even so, measurement is challenging, and the quantiﬁcation of
O2
•− production by isolated mitochondria is not done routinely.
In contrast with the difﬁculties of assessing O2
•− directly,
intramitochondrial O2
•− ﬂux can be readily measured in isolated
mitochondria following its dismutation to H2O2 by MnSOD and
subsequentdiffusionfromthemitochondria[11,54,55].Thereare
a number of ways of assaying this H2O2, but typically this is now
donebymeasuringtheoxidationofanon-ﬂuorescentdyebyH2O2
in conjunction with a peroxidase to form a ﬂuorescent product
(Figure2)[11,55–57].Althoughsuchassaysarereliable,sensitive
and robust, there are a number of issues to be considered in inter-
pretingthesedataandinextrapolatingfromisolatedmitochondria
to the in vivo situation. First, not all O2
•− is necessarily converted
into H2O2 in vivo,a ss o m eO 2
•− could react with other electron
acceptors or with NO
• within mitochondria [58,59]. Although
the extent of these reactions is not known, situations may arise
where they are signiﬁcant, particularly as physiological levels of
NO
• can react very rapidly with O2
•− (k≈10
10 M
−1 · s
−1)t of o r m
peroxynitrite (ONOO
−) [58,59]. Secondly, measurement of H2O2
efﬂux from mitochondria will also be affected by H2O2 produced
in the intermembrane space or outer membrane, which can be
signiﬁcant under some conditions [1,52,60]. Thirdly, and most
importantly, not all H2O2 produced within the mitochondrial mat-
rix will survive to efﬂux from the mitochondria, owing to matrix
peroxidases that consume H2O2 [1,61–63]. These include per-
oxiredoxins 3 and 5 [64], catalase [65,66] and glutathione
peroxidases 1 and 4 [67], with the peroxiredoxins probably of the
greatest signiﬁcance [64]. Thus the rate of matrix O2
•− formation
isthesumoftheH2O2 measuredefﬂuxingfromthemitochondria,
the O2
•− sinks, the rate of H2O2 degradation to water, minus H2O2
production from outside mitochondria (eqn 4) (Figure 2):
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1
2

d[O2
•−]
dt

Mito
=

d[H2O2]
dt

Measured
+
1
2

d[O2
•−]
dt

Sink
+

d[H2O2]
dt

Degr
−

d[H2O2]
dt

Ext
(4)
Consequently, there is a threshold of intramitochondrial O2
•−
formation before it exceeds scavenging by O2
•− sinks and
peroxidases, and generates sufﬁcient H2O2 to be measured
externally [1,61]. A corollary is that there may be signiﬁcant
O2
•− formation within mitochondria that goes undetected, which
is supported by the ﬁnding that H2O2 efﬂux from mitochondria
increases on inhibition of peroxidases [1,68]. An interesting
extension is that the activity of intramitochondrial peroxidases
such as peroxiredoxins is decreased on exposure to H2O2 [69–
71], and thus the mitochondrial H2O2-degradation rate may
vary considerably with condition and history of the organelle.
Consistent with this, exposure of mitochondria to H2O2 leads to
greaterH2O2 efﬂux[27],andmaybeonewayinwhichH2O2 efﬂux
from mitochondria is regulated by a feed-forward cycle of ROS-
induced ROS efﬂux. A related factor is that many mitochondrial
manipulations affect the activity of H2O2-degradation systems,
which are linked to the GSH/GSSG ratio through glutathione
peroxidases [67] and to the thioredoxin-2 oxidized/reduced
ratio through peroxiredoxins [62,63,68,72,73]. These in turn
are affected by the NADPH/NADP
+ ratio which is set by
the activity of the transhydrogenase and of NADP
+-dependent
isocitrate dehydrogenase [74,75]. Thus interventions that alter
mitochondrial substrate supply or  p could affect both O2
•−
production and matrix H2O2 degradation. Finally, it is generally
assumed that H2O2 permeates directly through the mitochondrial
membrane;however,H2O2 diffusionacrosstheplasmamembrane
is facilitated by aquaporins [76,77], and the possibility remains
that H2O2 from mitochondria may actually be protein-mediated,
perhaps leading to another level of control over H2O2 efﬂux.
Therefore, although inferring mitochondrial O2
•− production by
measuring H2O2 efﬂux is robust and reliable, a number of points
must be borne in mind when interpreting these data.
O2
•− PRODUCTION WITHIN ISOLATED MITOCHONDRIA
SufﬁcientstudieshavebeencarriedoutontheefﬂuxofH2O2 from
isolated mitochondria to enable generalizations about the condi-
tions that favour O2
•− production and the mitochondrial sources
of O2
•−. There are two main modes of operation by isolated mi-
tochondria that lead to extensive H2O2 efﬂux (Figure 3). The ﬁrst
modeoccurswhenthereisahighNADH/NAD
+ ratiointhematrix
[27,28]. The second mode is when there is a highly reduced CoQ
(coenzymeQ)pool,inconjunctionwithamaximal pandnoATP
synthesis [57,78,79]. The third mode of mitochondrial operation
is when the mitochondria are working normally making ATP (i.e.
theyarein,orcloseto,state3),orusingthe pforotherfunctions
suchasthermogenesis.Inthisthirdmodeofoperation,H2O2 efﬂux
from mitochondriaisnegligible comparedwith modes1or2.Our
next focus is to understand in detail the sites and mechanisms of
O2
•− production under these three modes of mitochondrial oper-
ation and thereby infer where and how O2
•− is produced in vivo.
Sites of O2
•− production within isolated mitochondria
Complex I
MammaliancomplexIistheentrypointforelectronsfromNADH
into the respiratory chain and is a ∼1 MDa complex comprising
45 polypeptides [80,81]. An FMN cofactor accepts electrons
from NADH and passes them through a chain of seven FeS (iron–
sulfur) centres to the CoQ reduction site, with another FeS centre
(N1a)closetotheFMN,butnotthoughttobeinvolvedinelectron
transfer to CoQ [80,81]. The structure of the water-soluble arm
Figure 3 Modes of mitochondrial operation that lead to O2
•− production
There are three modes of mitochondrial operation that are associated with O2
•− production. In
mode 1, the NADH pool is reduced, for example by damage to the respiratory chain, loss of
cytochrome c during apoptosis or low ATP demand. This leads to a rate of O2
•− formation at
the FMN of complex I that is determined by the extent of FMN reduction which is in turn set
by the NADH/NAD+ ratio. Other sites such as αKGDH may also contribute. In mode 2, there is
no ATP production and there is a high  p and a reduced CoQ pool which leads to RET through
complex I, producing large amounts of O2
•−. In mode 3, mitochondria are actively making ATP
and consequently have a lower  p than in mode 2 and a more oxidized NADH pool than in
mode1.Undertheseconditions,theﬂuxofO2
•− withinmitochondriaisfarlowerthaninmodes
1 and 2, and the O2
•− sources are unclear.
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of complex I from Thermus thermophilus, which contains
the FMN and the FeS centres, is known and is likely to be very
similar to that in mammals [80–82]. However, the structure of the
CoQ reduction site in the hydrophobic arm is not known and
the mechanism of proton pumping by complex I is uncertain
[80–82]. The Thermus structure indicates that the seven FeS
centres in the hydrophilic arm involved in passing electrons from
FMN to CoQ are reasonably well shielded from O2,s ot h a tO 2 is
most likely to access electron carriers at the FMN and CoQ sites,
although there are FeS centres at both termini which could also
donate electrons to O2 [81].
TheﬁrstdemonstrationofROSproductionbycomplexIwasin
SMPs where reduction of the CoQ pool and generation of a large
 p by succinate led to uncoupler-sensitive H2O2 production [83].
Subsequently,itwasshownthatisolatedcomplexIinthepresence
of NADH produces O2
•− and that this generation is enhanced
by the inhibitor rotenone which binds to the CoQ-binding site
[84]. The mechanism of O2
•− production by isolated complex I
is now reasonably well understood [28,85]. The isolated complex
produces O2
•− from the reaction of O2 with the fully reduced
FMN, and the proportion of the FMN that is fully reduced (PR)i s
set by the NADH/NAD
+ ratio [28,85]. This model explains why
inhibition of complex I with rotenone increases O2
•− production,
as it will lead to a back up of electrons onto FMN which will
produce O2
•− [86,87]. For complex I within intact mitochondria,
the proportion of fully reduced FMN is thought to be set by the
NADH/NAD
+ ratio, so inhibition of the respiratory chain by
damage, mutation, ischaemia, loss of cytochrome c or by the
build up of NADH due to low ATP demand and consequent low
respiration rate will increase the NADH/NAD
+ ratio and lead to
O2
•− formation [27,28,57,88–90]. In contrast, for most situations
where mitochondria are respiring normally on NADH-linked
substratesandtheNADH/NAD
+ ratioisrelativelylow,onlysmall
amounts of O2
•− are produced from complex I [87]. An elegant
demonstration of the importance of an elevated NADH/NAD
+
ratio for O2
•− production from complex I is that oxidation of
the NADH pool in mammalian mitochondria by expression of a
yeast NADH dehydrogenase decreases O2
•− production [91].
The other mechanism by which complex I produces large
amounts of O2
•− is during RET (reverse electron transport)
[7,27,87,89]. RET occurs for mitochondria operating in mode
2 when electron supply reduces the CoQ pool, which in the
presence of a signiﬁcant  p forces electrons back from CoQH2
into complex I, and can reduce NAD
+ to NADH at the FMN
site [92]. RET was ﬁrst associated with H2O2 production in
SMPs respiring on succinate [83,93]. Later, it was shown that
isolated mitochondria respiring on succinate, also generate large
amounts of O2
•− from complex I by RET [94]. Since then it has
become clear that there is extensive O2
•− production by RET at
complex I in isolated brain, heart, muscle and liver mitochondria
under conditions of high  p with electron supply to the CoQ
pool from succinate, α-glycerophosphate or fatty acid oxidation
[7,24,87,89]. This O2
•− production by RET is abolished by
rotenone, conﬁrming that it is due to electrons entering into
complex I through the CoQ-binding site(s) [95]. Of particular
note,thedependenceofRET-associatedO2
•− productionon pis
very steep and is abolished completely by a small decrease in  p
[79,87], presumably by decreasing the thermodynamic driving
force pushing electrons to the O2
•−-producing site(s) within
complex I. Intriguingly, O2
•− production by complex I is more
sensitive to changes in the  pH (pH gradient) component of the
 p, than to the  ψ (membrane potential) component [79,96].
The complex I site producing O2
•− during RET is unclear
[85,97]. The simplest possibility is that RET forces electrons
right back through complex I to the FMN, and that the site
of O2
•− production is the same during RET as it is for O2
•−
production from the reduced FMN in response to an elevated
NADH/NAD
+ ratio [85,89]. Consistent with this, the ﬂavin
inhibitorDPI(diphenyleneiodonium)blocksRET-associatedO2
•−
production by complex I [89]; however, this does not conﬁrm
the involvement of the FMN site, as DPI has other interactions
with mitochondria [97]. Furthermore, disruption of the CoQ-
binding site in complex I under conditions where there was a high
 p Hl e dt of a rm o r ee x t e n s i v eO 2
•− production than reduction
of FMN alone, suggesting a role for the CoQ-binding site in
RET O2
•− production [95]. In addition, there is not a unique
relationship between the mitochondrial NADH/NAD
+ ratio and
O2
•− production by complex I under different conditions [98].
This suggests that O2
•− production from complex I may occur
both by RET and from the reduction of FMN by the NADH pool
simultaneously,andthatmostoftheO2
•− generatedduringRETis
not produced at the FMN. If O2
•− is not produced at FMN during
RET, then the focus shifts to the CoQ-binding site, where two
electrons are passed from the N2 FeS centre to CoQ, reducing
it to CoQH2, while pumping four H
+ across the mitochondrial
inner membrane by an unknown mechanism. The intriguing
pH- and  pH-dependence of O2
•− production during RET [79]
may suggest that critical semiquinones and semiquinolates are
formed during proton pumping that react directly with O2 to
form O2
•− [57,88,95]. However, our lack of knowledge of the full
structureofcomplexIanditsexactmechanismofprotonpumping
hampersprogress.Morepositively,itmaybethatinvestigatingthe
mechanism of O2
•− production [95], and the unusual interaction
of complex I with electron acceptors during RET [44], may shed
light on the mechanism of proton pumping by complex I.
To summarize, complex I produces large amounts of O2
•− by
two mechanisms: when the matrix NADH/NAD
+ ratio is high,
leading to a reduced FMN site on complex I, and when electron
donation to the CoQ pool is coupled with a high  pl e a d i n gt o
RET (Figure 4). Although the site of O2
•− production during RET
is not known, the rate of O2
•− production under RET seems to be
the highest that can occur in mitochondria [71,79,95].
Complex III
ComplexIIIfunnelselectronsfromtheCoQpooltocytochromec.
The monomer is ∼240 kDa and comprises 11 polypeptides, three
haems and an FeS centre, and it interacts transiently with CoQ
duringtheQ-cycleattheQi andQo sites[99].ComplexIIIhasfora
long time been regarded as a source of O2
•− within mitochondria
[84,100]. When supplied with CoQH2 and when the Qi site is
inhibited by antimycin, complex III produces large amounts of
O2
•− from the reaction of O2 with a ubisemiquinone bound to the
Qo site[84,89,100–103].ThisO2
•− isreleasedfromcomplexIIIto
both sides of the inner membrane [24,27,52,104]. However, in the
absenceof antimycin, the Qo site ubisemiquinoneis not stabilized
and O2
•− production by complex III is low [105]. Inhibition of
respiration at points distal to complex III with cyanide or by loss
of cytochrome c does not increase O2
•− production by complex
III [100], therefore reduction of the CoQ pool is not sufﬁcient to
generate O2
•− at complex III. It may be that high  p stabilizes the
Qo siteubisemiquinone;however,theveryhighproductionofO2
•−
bycomplexIduringRETinthepresenceofsuccinateisabolished
completely by rotenone [87,95]. Under these conditions, there
is a large  p and a reduced CoQ pool, suggesting that the
maximalO2
•− productionbyuninhibitedcomplexIIIisnegligible
compared with that by complex I during RET. However, it is
possible that, for mitochondria operating in mode 3, when O2
•−
production by complex I is low, the contribution of complex III
to the overall O2
•− ﬂux may then become relatively signiﬁcant.
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Figure 4 Production of O2
•− by complex I
The cartoon of complex I is a chimaera modelled on the hydrophobic arm of Yarrowia lipolytica obtained by electron microscopy [132] and the crystal structure of the hydrophilic arm from Thermus
thermophilus [82]. The location of the FMN and the FeS centres in the water-soluble arm are indicated, along with the putative CoQ-binding site. In mode 1, there is extensive O2
•− production from
the FMN in response to a reduced NADH pool. In mode 2, a high  p and a reduced CoQ pool lead to RET and a high ﬂux of O2
•− from the complex. The site of this O2
•− production is uncertain,
hence the question mark, but may be associated with the CoQ-binding site(s).
Under these conditions, factors that affect the stability of the
ubisemiquinone radical in the Qo site, such as loss of cytochrome
c or changes in  p or in the redox state of the CoQ and cyto-
chrome c pools, may modulate O2
•− production. Therefore,
although complex III can be induced to produce O2
•− with
the inhibitor antimycin, its production in mitochondria under
physiological conditions is far lower and is negligible compared
with the maximum rates of O2
•− production from complex I.
Other sites of O2
•− production within mitochondria
Many other sites within mitochondria may also produce O2
•− or
H2O2.Itisconvenienttodividemostoftheseintositesthatinteract
with the matrix NADH pool and those that are connected to the
CoQ pool within the inner membrane.
When respiratory chain activity is low, or when there is RET,
the NADH/NAD
+ ratio will increase and this may lead to O2
•−
production at other sites connected to the NADH pool, in addition
to complex I. When complex I is inhibited with rotenone,
there is a reduced NADH pool and ROS production from
complex I, but addition of 2-oxoglutarate (α-ketoglutarate) as a
substrate increases ROS production further, suggesting that the
combination of 2-oxoglutarate with a reduced NADH pool may
lead to signiﬁcant ROS production from αKGDH [2-oxoglutarate
dehydrogenase (α-ketoglutarate dehydrogenase)] [7,106–108].
One component of αKGDH is dihydrolipoamide dehydrogenase,
which contains a ﬂavin that can produce ROS when its
electron acceptor NAD
+ is limiting [7,106–108]. Decreasing
the expression of dihydrolipoamide dehydrogenase in mouse
ﬁbroblasts decreased O2
•− production in mitochondria isolated
from these cells [7,106–108]. A similar situation may exist for
other enzymes that contain dihydrolipoamide dehydrogenase,
such as pyruvate dehydrogenase, but their capacity for O2
•−
productionseemstobelessthanthatofαKGDH[106].Therefore,
under conditions of high NADH/NAD
+ ratio, not only complex I,
but also αKGDH,andperhapsotherenzymeslinkedtotheNADH
pool, may contribute to O2
•− production in a manner that depends
onthemitochondrialsubstrates.Itmaybethatwhenmitochondria
are operating in mode 3 and are actively making ATP, O2
•−
production from complex I is negligible and the contribution
from sites such as αKGDH is proportionally more signiﬁcant
[106].
Many potential sites of O2
•− production interact with the CoQ
pool. Fatty acid oxidation in the matrix reduces ETF (electron
transfer ﬂavoprotein) which passes its electrons to CoQ via
ETF:CoQoxidoreductaseonthematrixsurfaceoftheinnermem-
brane[109].Oxidationofpalmitoyl-CoAbymitochondrialeadsto
H2O2 production [12,90], primarily from RET at complex I; how-
ever, ETF:CoQ reductase may itself produce ROS [24]. Dihydro-
orotatedehydrogenaseontheoutersurfaceoftheinnermembrane
catalysesoxidationofdihydro-orotatetoorotatewithreductionof
CoQ, and dihydro-orotate oxidation is associated with mitochon-
drial O2
•− production [110]; however, it is uncertain whether O2
•−
isproducedbydihydro-orotatedehydrogenaseitself.Ontheouter
surface of the inner membrane, αGPDH (α-glycerophosphate
dehydrogenase) takes electrons from α-glycerophosphate to CoQ
[111–113]. In brown adipose tissue mitochondria [112], and in
Drosophila mitochondria [114], oxidation of α-glycerophosphate
is associated with ROS production, much of this due to RET from
complex I, although some is produced from αGPDH itself on
the outer surface of the mitochondrial inner membrane [113].
However, the physiological signiﬁcance of this is unclear, as
αGPDH is expressed at relatively low levels in most mammalian
tissues[111,112],althoughitmaybeimportantinthebrain[113].
Complex II oxidizes succinate passing electrons to CoQ, but,
although the damaged or mutated complex can produce ROS
[101,115], it seems that all O2
•− production during succinate
oxidation arises from complex I by RET. Therefore the activity
of a number of CoQ-linked enzymes is associated with increased
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ROS production, primarily by favouring RET at complex I, but,
in some cases, they may produce ROS directly themselves.
In addition to the sites discussed above, there are many other
mitochondrial enzymes that can be induced to produce O2
•− or
H2O2.SomeofthesearenotconnectedtotheNADHorCoQpools,
such as the adrenodoxin reductase/adrenodoxin/cytochrome P450
systeminthemitochondrialmatrixthatreceiveselectronsfromthe
NADPH pool [116,117]. Therefore it is probable that many other
sites of mitochondrial O2
•− production remain to be discovered,
but whether they make a quantitatively signiﬁcant contribution to
mitochondrial ROS production under physiological conditions is
unclear [1].
Overview of O2
•− production by isolated mitochondria
It is possible to draw some tentative conclusions about O2
•−
production by isolated mitochondria. Two modes of operation
lead mitochondria to produce large amounts of O2
•−: mode 1,
when there is a build up of NADH, and mode 2, when there is a
large  p and a reduced CoQ pool (Figure 3). In both modes, the
predominant site of O2
•− production is complex I, in keeping with
a growing view that complex I is the major source of O2
•− within
mitochondria in vivo [1,7,85,118]. Even so, the accumulation of
NADH that occurs in modes 1 and 2 may lead to O2
•− production
from other sites such as αKGDH. The mechanisms of O2
•−
production from complex I in the two modes are quite distinct,
being by reduction of FMN by NADH in mode 1 and by RET in
mode 2. Of course, in some situations, both mode 1 and mode 2
may operate simultaneously when a build up of NADH and CoQ
coincides with a high  p.
The mode 1 production of O2
•− probably occurs in vivo under
conditionswheredamagetotherespiratorychain,slowrespiration
or ischaemia leads to a build up of NADH. This may occur during
cytochrome c release in apoptosis and following inhibition of res-
piration at cytochrome oxidase by NO
•. Treatments that oxidize
the NADH pool, such as overexpressing NADH oxidases, should
decrease the production of O2
•− in mode 1, while rotenone and
other respiratory inhibitors should increase it (antimycin would
not be diagnostic here as it will increase O2
•− production at com-
plexIII).Whethermode2O2
•− productionoccursinculturedcells
orinvivoisnotknown.Ifitdoes,itwouldbeassociatedwithahigh
 pandareducedCoQpool,andwillbeverysensitivetomildun-
coupling and to inhibition by rotenone. The generation of O2
•− by
bothmodes1and2willbedecreasedbymilduncoupling,perhaps
suggestingthatthephysiologicalfunctionofuncouplingproteins-
2 and -3 is to modulate mitochondrial O2
•− production [118].
Mode 3 occurs when mitochondria are synthesizing ATP or
utilizing  p for other functions. Under these conditions, the
lowered pandtheoxidizedNADHpoolpreventO2
•− production
by RET and greatly decrease O2
•− production at the FMN of
complex I, making H2O2 efﬂux from mitochondria negligible
compared with modes 1 or 2 (e.g. [4,78,89,119]). However,
there may still be O2
•− production within mitochondria operating
in mode 3 that is below the threshold consumed by mitochondrial
peroxidases (eqn 4) [68]. Although the sites of this putative
O2
•− production in mode 3 are unclear, complex I, complex
III and matrix enzymes such as αKGDH could all contribute.
A further complication is that in vivo substrate supply to the
respiratory chain is stringently regulated by factors such as
dietary and hormonal status, leading to alterations in the steady-
state reduction potential of mitochondrial electron carriers.
As mitochondria in vivo probably spend much of their time
synthesizing ATP, this mode of O2
•− production may account for
most of the overall exposure of mitochondria to O2
•−.T h u s ,e v e n
though the rate of O2
•− production in mode 3 is relatively low
and the sources are poorly understood, it may turn out to be the
mode of greatest biological importance and be responsible for
the long-term accumulation of mitochondrial oxidative damage
andfortheextensivetissuedamageseenintheabsenceofMnSOD
[45,46].
THE PARADOX OF HYPOXIC H2O2 PRODUCTION BY MITOCHONDRIA
Figure 3 gives a reasonable description of mitochondrial O2
•−
production. However, mitochondrial ROS production is also
reported to increase under conditions of very low [O2], which
is paradoxical and seems to contradict the dependence of
mitochondrial O2
•− production on [O2] given in eqn (2). These
hypoxic effects are seen in cultured cells when ambient O2 is
decreasedfrom21%O2 to1–3%O2 [120,121].Thiscorresponds
to an equilibrium [O2] of 10–20 μM, although the local [O2]
around mitochondria will be lower.
The discovery of increased mitochondrial ROS production
during hypoxia arose from investigations of HIF-1 (hypoxia-
inducible factor-1), which plays a central role in the response of
cells to hypoxia [122,123]. HIF-1 is a heterodimer comprising
HIF-1α and HIF-1β that translocates to the nucleus and there,
in association with other proteins, initiates transcription of a
number of genes in response to hypoxia [122,123]. HIF-1α
is constitutively expressed, but, under normoxia, it is rapidly
hydroxylated on proline residues by PHD (prolyl hydroxylase),
which uses 2-oxoglutarate and O2 as substrates, marking
HIF-1α for rapid degradation by the ubiquitin–proteasome
system [122,123]. When the [O2] falls, HIF-1α is no longer
degraded, allowing the HIF-1 heterodimer to form and induce
the transcription of a series of hypoxia-sensitive genes. Further
regulation of HIF-1 occurs because PHD activity is sensitive to
H2O2, probably through reaction with non-haem iron in its active
site [120,121]. Thus the mitochondrial respiratory chain may
act as an O2 sensor, releasing H2O2 under hypoxic conditions to
decreases the activity of PHD, thereby stabilizing HIF-1α and
modulating its response to hypoxia [120,121].
The evidence that hypoxia increases mitochondrial ROS pro-
duction in cultured cells comes from measurements of cytosolic
ROS using several different probes, and from showing that the
effects of hypoxia-induced mitochondrial ROS on HIF-1 can
be blocked by mitochondria-targeted antioxidants [120,121,124].
Further studies have shown that a functional respiratory chain is
required, that loss of cytochrome c, or the Rieske FeS centre of
complex III, abolishes this ROS signal [121,125], and that the
direct addition of H2O2 overcomes this blockade [126]. These
studies have led to the proposal that the source of the ROS
is complex III [121], possibly a ubisemiquinone at the Qo site
[126]. Although ongoing work may reﬁne details of this model,
the question remains of how lowering [O2] can increase H2O2
efﬂux from mitochondria. When isolated mitochondria were
maintained at low [O2], ROS production decreased as the [O2]
was lowered from approx. 5 μMO 2 to anoxia [29]. This ﬁnding
makes it unlikely that the decrease in [O2] itself affects O2
•−
production directly, for example by altering the stability of the
ubisemiquinone radical at complex III, the rate of degradation
or release of H2O2 from mitochondria or the sidedness of O2
•−
releasefromcomplexIII[104,121].Insteaditsuggeststhatthelow
[O2] environment requires additional factors that occur in the hy-
poxic cell environment to increase mitochondrial ROS efﬂux.
For example, changes in [NO
•] might modulate the response of
cytochrome oxidase to low [O2] [127], thereby altering the PR
of protein redox groups. Alternatively, hypoxia could act through
cell signalling pathways to decrease the activity of mitochondrial
matrix or intermembrane space peroxidases, thereby increasing
c   The Authors Journal compilation c   2009 Biochemical Society © 2008 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commerical use, distribution and reproduction in any medium, provided the original work is properly cited.How mitochondria produce reactive oxygen species 9
mitochondrial H2O2 efﬂux. Clearly, more work is required to un-
ravel the mechanism of increased mitochondrial ROS production
during hypoxia, but it remains an intriguing puzzle, and our un-
derstanding of mitochondrial ROS production will be incomplete
until there is a satisfactory explanation for this phenomenon.
HOW MUCH O2
•− DO MAMMALIAN MITOCHONDRIA PRODUCE
IN VIVO?
To investigate the signiﬁcance of mitochondrial O2
•− production
in oxidative damage and redox signalling, it is necessary to know
howmuchO2
•− isgeneratedbymitochondriainvivo.Thegreatest
rate of H2O2 production by isolated mitochondria occurs during
mode 2 when mitochondria have a high  p, a reduced CoQ pool
and are not making ATP. Under these conditions, ROS production
is primarily by RET at complex I, and approx. 1–2% of the
O2 consumed by isolated mitochondria under these conditions
forms O2
•− [1,4,27]. Since it was ﬁrst published by Chance and
colleagues [4,12], this value of 1–2% of respiration going to
O2
•− has propagated through the literature and has been used
erroneously to estimate mitochondrial O2
•− production in vivo,
even though the original authors made it clear that it only applied
to particular experimental conditions [12].
Several factors make extrapolation of H2O2 production by
isolated mitochondria to the in vivo situation invalid. First,
maximal O2
•− production by isolated mitochondria occurs during
RETusingsaturatinglevelsofsubstratessuchassuccinate,which
are at lower concentrations in vivo. When lower concentrations
of succinate are used, approx. 0.4–0.8% of respiration produces
H2O2 [57],whileuseofthephysiologicalsubstratepalmitoyl-CoA
decreases H2O2 production to approx. 0.15% of respiration [24],
and, when glutamate/malate are used as substrates, H2O2 produc-
tion accounts for approx. 0.12% of respiration [27]. Secondly,
measurements on isolated mitochondria are generally made using
air-saturatedmediumcontaining∼200 μMO 2.Asmitochondrial
O2
•− productionisprobablyproportionalto[O2]andthephysiolo-
gical [O2] around mitochondria is approx. 10–50 μM, O2
•−
productionmaybe5–10-foldlowerthanforisolatedmitochondria
in the same state. The third and most important factor limiting
extrapolation of in vitro O2
•− production to the situation in vivo is
thatmitochondriainvivoarelikelytobemakingATPandwillthus
be operating in mode 3 with a lowered  p and relatively oxidized
NADH and CoQ pools. Consequently, their rates of H2O2 efﬂux
are negligible compared with modes 1 or 2. Therefore, although
it is valid to say that 0.12–2% of respiration goes to O2
•− in vitro,
these values cannot be extrapolated to the in vivo situation where
mitochondrial O2
•− production will be far, far lower.
Allowing for these caveats, can we estimate roughly how much
O2
•− is produced by mitochondria in vivo? Unfortunately the
answer at the moment is no, because we know little about basic
mitochondrial function in vivo. For example, the proportion of
time that mitochondria spend actively making ATP (i.e. in state 3)
or with a high  p and a low rate of ATP synthesis (i.e. in state 4)
in vivo is not known. The proportion of mitochondria with a
reduced NADH pool and whether RET occurs in vivo are also
unclear. If, as is probable, mitochondria in vivo spend most of
their time close to state 3, then we have very limited knowledge
of how much O2
•− production occurs in the matrix. Therefore,
although there is considerable evidence for the accumulation
of oxidative damage within mitochondria in vivo [3,128], from
which we can infer that mitochondrial ROS production does
occur, it is difﬁcult to estimate the ﬂux of mitochondrial O2
•−
that leads to this damage.
Although estimates of mitochondrial O2
•− production as a
proportion of respiration rate are not possible, can we infer from
studies of mitochondria ex vivo the extent of O2
•− production in
vivo? The maximum O2
•− production rate in vivo is proportional
to the content of respiratory complexes such as complex I, and
thus correlates with maximum respiration rate. However, as the
actual O2
•− production rate depends so closely on factors such
as  p and NADH/NAD
+ ratio, which vary markedly in vivo,
it is not possible to say that changes in ROS production by
mitochondria isolated from animals of different ages or hormonal
status bear any relation to differences in mitochondrial ROS
production in vivo. Is it at least possible to infer in vivo rates of
mitochondrial O2
•− production from direct measurements of ROS
withinlivingtissue? Atthemoment,theanswerisalsono,because
quantiﬁcation is challenging and currently there are no reliable
estimates of mitochondrial O2
•− production in vivo. A classic
estimate of H2O2 production was made in perfused liver where
H2O2 production by the whole organ was measured from changes
in catalase compound I [129]. Approx. 80 nmol of H2O2/min per
g of wet weight was produced in the tissue [127], with about
12 nmol of H2O2/min per g of wet weight estimated to come
from mitochondria [90]. However, one of the many assumptions
made in this work was that mitochondrial H2O2 production
in situ was the same as for isolated mitochondria respiring on
succinate, when they would have been producing H2O2 by RET
[90]. Therefore we know little about the actual ﬂux of O2
•−
within mitochondria in vivo, about how it changes under different
physiological circumstance, or about its quantititive importance
relativetoothersourcesofROS.Moreworkisrequiredtodevelop
methods to measure mitochondrial ROS production in vivo.
CONCLUSIONS
I have outlined the factors that lead to O2
•− production within
isolated mitochondria and have shown that there are two modes
of high O2
•− production, predominantly, but not exclusively, from
complex I: by RET when the  p is high and the CoQ pool is
reduced, and from the FMN when the NADH/NAD
+ ratio is high
(Figure 3). When mitochondria are actively making ATP, the rate
of O2
•− production is far lower and the sites of production are
uncertain. This suggests that in vivo conditions leading to RET or
anaccumulationofNADHwillfavourO2
•− production.However,
the extent to which these situations arise in vivo is not known,
and, at the moment, it is not possible to estimate the rate of mito-
chondrial O2
•− production in vivo. Even so, the description given
here of the factors underlying mitochondrial O2
•− production will
enable the design and interpretation of experiments to assess the
physiologicalandpathologicalsigniﬁcanceofmitochondrialROS
production in vivo. One area where such knowledge is vital is in
the large number of pathologies where mitochondrial disruption
leads to oxidative damage [3,5]. This raises the possibility that
better understanding of how mitochondria produce ROS will lead
to the rational design of therapies to minimize mitochondrial
oxidative damage [130]. Also important is the likelihood that
ROS production by mitochondria is a redox signal integrating
mitochondrial function with that of the rest of the cell [3,9].
Redox signalling can occur by mitochondria releasing H2O2 that
modulates the activity of target proteins through the reversible
oxidationofcriticalproteinthiols[9,131],thusalteringtheactivity
of enzymes, kinases, phosphatases and transcription factors in
mitochondria, the cytosol or the nucleus (Figure 5). Although
little is known currently about mitochondrial redox signalling,
the description of ROS production developed here shows how
it can occur and will prove useful in investigating this rapidly
developing area. For example, mitochondrial H2O2 efﬂux could
act as a retrograde signal to the cell, reporting on mitochondrial
 p or the redox state of the NADH pool, and thus enable
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Figure 5 Possible mechanisms of mitochondrial redox signalling
The production of H2O2 from mitochondria is a potential redox signal. H2O2 generated by mitochondria can reversibly alter the activity of proteins with critical protein thiols by modifying them to
intra- or inter-protein disulﬁdes, or to mixed disulﬁdes with GSH. These modiﬁcations can occur on mitochondrial, cytosolic or nuclear enzymes, carriers or transcription factors, transiently altering
their activities. The change in activity can be reversed by reducing the modiﬁed protein thiol by endogenous thiol reductants such as GSH or thioredoxin. As the extent of H2O2 production from
mitochondriawilldependonfactorssuchas portheredoxstateoftheNADHpool,itcanactasaretrogradesignaltotherestofthecell,reportingonmitochondrialstatus.Thissignalcanthenlead
to the short-term modiﬁcation of, for example, pathwayssupplying substrates to the mitochondria.Alternatively, longer-term modiﬁcationscan occur throughmodifying redox-sensitive transcription
factorsthat adjusttheproductionofmitochondrialcomponents.In addition,externalsignalsmaymodifyO2
•− productionbytherespiratorychain bypost-translational modiﬁcation.Alteration ofthe
activity of mitochondrial peroxidases could also modulate H2O2 efﬂux from mitochondria to the rest of the cell. It is also possible that secondary redox signals, such as lipid peroxidation products
derived from H2O2, could act as secondary redox signals.
the activity, transcription, translation, import or degradation of
mitochondrial components to be adjusted accordingly. It is also
likely that external signals can alter O2
•− production through
the post-translational modiﬁcation of the respiratory chain, or
by altering H2O2 efﬂux from mitochondria by modulating the
activity of matrix peroxidases such as peroxiredoxins. However,
it is clear that to address these vital issues, better methods are
required to assess mitochondrial  p and the reduction potential
of critical redox couples within mitochondria in vivo, and thus
enable the tendency of mitochondria to produce O2
•− to be
inferred. Furthermore, techniques to measure the production of
mitochondrial O2
•− and H2O2 directly in vivo also need to be
developed. Such innovations are essential to understand the role
of mitochondrial O2
•− production in redox signalling and in
pathological oxidative damage.
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